A New York woman files a new Stryker Rejuvenate injury lawsuit, alleging she suffered severe adverse health effects and complications due to being implanted with the Rejuvenate Modular hip stem.

According to the Stryker Rejuvenate lawsuit, the plaintiff, Bega K., was implanted with the Rejuvenate Modular hip stem on her left hip on Aug. 26, 2010 at NYW Hospital.

The Styker Rejuvenate lawsuit contends that the plaintiff could not have known of any potential injuries that may result because of the hip implant since the recall of the medical device was announced after her hip implant surgery.

Moreover, she contends that she could not have known that she would be, “injured by excessive levels of chromium and cobalt until after the date that [she] had [her] blood drawn and [she] was advised of the results of said blood-work and the fact that those blood work abnormalities were attributable to a defect in the device(s) at issue,” the Stryker Rejuvenate lawsuit states.

Stryker Rejuvenate Lawsuit Joins Others in MDL

Bega’s claim is filed as part of a large multidistrict litigation, or MDL, centered on allegations that the medical device, comprised of a single piece of titanium alloy and manufactured by maker and defendant Howmedica Osteonics and Stryker Orthopaedics causes severe adverse health effects and serious complications.

The Stryker Rejuvenate lawsuit alleges that the Stryker medical device is metal-on-metal. The implant system is comprised of a metal acetabular cup and a metal femoral stem. When implanted into a patient’s hip, however, the metal parts can cause a condition known as metallosis. This occurs when the metal parts rub together and cause the release of tiny metal particles into the patient’s bloodstream or the soft tissue.

With metallosis, the metal particles to build-up and deposit themselves into the patient’s soft tissue. The result of this condition can become very painful. The soft tissue surrounding the metal hip implant can become very damaged and cause soft tissue growths, inflammation, bone loss, pain, and swelling.

The Stryker Rejuvenate lawsuit contends that the makers manufactured, marketed, and promoted the defective product to be implanted into men’s and women’s hips as a replacement device. However, patients have suffered and may continue to suffer from these severe adverse health effects and complications from the Stryker Rejuvenate hip implant.

When first allegedly marketing the medical device, the Stryker Rejuvenate lawsuit claims that the device was, “tested and proved by defendants to resist the effects of corrosion and fretting.”

According to the Stryker Rejuvenate lawsuit, Howmedica and Stryker had received FDA clearance in 2008 for the device, but they issued a voluntary recall of the hip implant in July 2012.

The Stryker Rejuvenate Lawsuit is Case No. 0:17-cv-03025-DWF-FLN, in the U.S. District Court for the District of Minnesota. The Stryker Hip Implant MDL is In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 13-2441, in the U.S. District Court for the District of Minnesota.